Cornerstone Biopharma Inc., et al. v Exela Pharma Sciences LLC, et al., C.A. No. 13-1275 - GMS, July 9, 2015
Sleet, J. The court construes 4 terms in a case with four patents in suit.
The following terms are construed:
- A pre-mixed aqueous solution (The court adopts the TTAB’s construction)
- Buffer in an amount to maintain PH from about 3.6 to about 4.7
- One year or three months “at room temperature”